rs1554604482
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001382391.1(CSPP1):c.2527dupG(p.Glu843GlyfsTer31) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. E843E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001382391.1 frameshift
Scores
Clinical Significance
Conservation
Publications
- Joubert syndrome 21Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
 - Joubert syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 - Joubert syndrome with Jeune asphyxiating thoracic dystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 - Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CSPP1 | NM_001382391.1  | c.2527dupG | p.Glu843GlyfsTer31 | frameshift_variant | Exon 21 of 31 | ENST00000678616.1 | NP_001369320.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CSPP1 | ENST00000678616.1  | c.2527dupG | p.Glu843GlyfsTer31 | frameshift_variant | Exon 21 of 31 | NM_001382391.1 | ENSP00000504733.1 | 
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD4 exome Cov.: 31 
GnomAD4 genome  Cov.: 32 
ClinVar
Submissions by phenotype
Joubert syndrome 21    Pathogenic:1 
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 541695). This variant has not been reported in the literature in individuals affected with CSPP1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu838Glyfs*31) in the CSPP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CSPP1 are known to be pathogenic (PMID: 24360807, 24360808). -
not provided    Pathogenic:1 
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at